Second Primary Breast Cancer in Young Breast Cancer Survivors
This cohort study examines the risk of a second primary breast cancer in women who were aged 40 years or younger when first diagnosed with breast cancer.
This cohort study examines the risk of a second primary breast cancer in women who were aged 40 years or younger when first diagnosed with breast cancer.
A new drug application seeking the approval of toripalimab for the treatment of patients with nasopharyngeal carcinoma is under review in Hong Kong.
HER2 gene expression is associated with prognostic and predictive value in patients with metastatic colorectal cancer.
For those going through cancer treatment, it can be hard to not only find something that makes the body feel good, but tastes good, too.
Frontline nivolumab plus chemotherapy has been recommended for approval in unresectable or metastatic urothelial carcinoma.
This cohort study estimates the prevalence of vaccination receipt among pregnant people with HIV and identifies demographic and clinical characteristics associated with vaccination.
Advances in biomedical research require a robust physician scientist workforce. Despite being equally successful at securing early career awards from the NIH as men, women…
This cross-sectional study analyzes disparities in cancer stage at diagnosis within and outside the catchment area of a comprehensive cancer center across a 10-year period.
Robert W. Mutter, MD, discusses personalized treatment approaches with radiation and endocrine therapy with
This cohort study evaluates recent reversals in declines in cardiovascular mortality and whether they vary across sociodemographic categories.
Advances in biomedical research require a robust physician scientist workforce. Despite being equally successful at securing early career awards from the NIH as men, women…